Who backs Imbria Pharmaceuticals?
9 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Catalio Capital Management | Venture capital |
| SV Health Investors | Venture capital |
| Deep Track Capital | Venture capital |
| AN Ventures | — |
| AXA IM Alts | — |
| Blackwell Partners | — |
| Cytokinetics | — |
| Sanofi Ventures | — |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Imbria Pharmaceuticals investors
9 investors are on record for Imbria Pharmaceuticals, including RA Capital Management, Catalio Capital Management, SV Health Investors and Deep Track Capital. The Series B in Dec 2025 drew 6 investors.
Free account
More of Imbria Pharmaceuticals with a free account
- ·Watch Imbria Pharmaceuticals: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 9 firms already write checks for companies like Imbria Pharmaceuticals in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View